Regeneron Pharmaceuticals (REGN)
Short-Term Debt
$0.00
Quarterly · Period ending: · USD

REGN Short-Term Debt
Latest reported$0.00period ending
Latest reported$0.00period ending
REGN Quarterly Short-Term Debt ($0.00 → $0.00)
Quarterly short-term debt
High-resolution chart · PNG
REGN short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 0 | |
| 720,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 719,700,000 | |
| 719,000,000 | |
| 718,400,000 | |
| 717,800,000 | |
| 0 | |
| 0 | |
| 1,500,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 7,200,000 | |
| 129,557,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,252,000 | |
| 1,060,000 | |
| 1,060,000 | |
| 939,000 | |
| 794,000 | |
| 794,000 | |
| 1,473,000 | |
| 1,374,000 | |
| 1,277,000 | |
| 1,183,000 | |
| 1,093,000 | |
| 1,006,000 | |
| 920,000 | |
| 877,000 | |
| 798,000 | |
| 675,000 | |
| 634,000 | |
| 448,000 | |
| 435,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 117,503,000 | |
| 118,653,000 | |
| 200,000,000 | |
| 200,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 13,817,000 | |
| 9,296,000 | |
| 0 | |
| 61,000 | |
| 150,000 | |
| 237,000 | |
| 324,000 | |
| 412,000 | |
| 426,000 | |
| 523,000 |